The DESTINY-Breast11 trial showed in patients with high-risk HER2-positive early breast cancer that the ADC followed by ...
New preclinical data for PM577 in Wilson’s Disease (WD) to be presented at AASLD; on-track to file IND and/or CTA in H1’26, with initial ...
The U.S. Food & Drug Administration (FDA) has awarded a Commissioner's National Priority Voucher (CNPV) for HERNEXEOS® (zongertinib tablets), currently under investigation for first-line use in ...
MADRID and CAMBRIDGE, Mass., Nov. 07, 2025 (GLOBE NEWSWIRE) -- Oryzon Genomics, S.A. (ISIN Code: ES0167733015, ORY), a clinical-stage biopharmaceutical company and a European leader in epigenetics, ...
AI-driven tools are seen to strengthened cybersecurity defenses through various ways such as anomaly detection, predictive analytics, and automated incident response, the same technologies are also ...
DelveInsight's Endometrial Cancer Market Insights report includes a comprehensive understanding of current treatment practices, endometrial cancer emerging drugs, market share of individual therapies, ...
So, what are retrons? They’re bacterial immune systems that save the bacterial herd by culling individual bacteria infected ...
The northern and southern maned sloths may look very similar from the outside, but their genomes reveal different stories: ...
A biomedical researcher combining advanced mouse models with human-based and computational approaches explains why we can’t ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback